ESG Report

Overview

The report presents CF Pharma and Patriapharma's first ESG report, covering progress from January 2021 to December 2022. It reports 748 T/YEAR of total waste in 2022, an 18-20% annual reduction in energy consumption and an 84% recycled-versus-final-disposal waste rate. It also describes solvent recirculation, green-chemistry work, employee health and community programmes, and compliance initiatives including zero serious breaches. Carbon-footprint modelling and formal external validation were still future or in-progress activities.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2023
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services